Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
31.57
-0.04 (-0.11%)
Jun 10, 2026, 12:34 PM EDT - Market open
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $2.2 billion as of June 10, 2026. Its market cap has increased by 152.37% in one year.
Market Cap
2.20B
Enterprise Value
1.92B
1-Year Change
152.37%
Ranking
Category
Stock Price
$31.57
Market Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $2.20B, an increase of 245.33%. That is a compound annual growth rate of 26.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 2.20B | 22.13% |
| Dec 31, 2025 | 1.80B | 73.39% |
| Dec 31, 2024 | 1.04B | -28.87% |
| Dec 29, 2023 | 1.46B | 284.53% |
| Dec 30, 2022 | 380.11M | -20.27% |
| Dec 31, 2021 | 476.72M | -25.14% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Disc Medicine | 2.51B |
| Definium Therapeutics | 2.51B |
| Alumis | 2.42B |
| Vera Therapeutics | 2.28B |
| Celldex Therapeutics | 2.24B |
| Ultragenyx Pharmaceutical | 2.12B |
| Immunome | 2.11B |
| Enliven Therapeutics | 2.05B |